U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07420647) titled 'Pilot Study of Individualized Treatment for Genitourinary Syndrome of Menopause in Women After Cancer Treatment' on Feb. 04.
Brief Summary: This pilot study is designed to evaluate an individualized approach to the treatment of genitourinary syndrome of menopause (GSM) in women who have undergone oncological treatment. GSM is a common condition in postmenopausal women and may include symptoms such as vaginal dryness, irritation, pain during intercourse, and urinary discomfort. These symptoms can significantly affect quality of life and sexual function, particularly in women after cancer treatment.
The purpose of this study is to as...